The COVID-19 pandemic, the Russia-Ukraine war and other global factors have created a variety of supply chain issues for healthcare systems across the U.S.
Leaders from kidney organizations wrote a letter to White House officials April 8 urging them to prioritize the needs of kidney disease patients by addressing staff shortages and supply chain disruptions at dialysis centers across the country.
Johnson & Johnson must pay $302 million to California for “many years of deceptive marketing” about pelvic mesh implants with the potential to cause serious vaginal pain and damage, The San Francisco Chronicle reported April 11.
While global supply chain disruptions resulting from China’s lockdowns to curb COVID-19 outbreaks have been minor, experts say that major disruptions are a growing possibility, The Guardian reported recently.
Global Healthcare Exchange named 78 healthcare provider and supplier organizations to the 2021 GHX Millennium Club, which honors organizations that achieved the highest levels of automation.
Experts say while global supply chain disruptions have been “relatively minor” thus far from China’s lockdowns to curb COVID-19 outbreaks, major disruptions are a growing possibility, The Guardian reported April 6.
Supply and labor shortages related to the COVID-19 pandemic forced ASCs to spend more on both in 2020 and 2021. But with the number of COVID-19 cases and hospitalizations waning, will supply and labor costs drop?